|
Delayed
Hong Kong S.E.
01:24:38 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 1.035 HKD | -1.43% |
|
-4.17% | -22.76% |
| 09-20 | SinoMab BioScience Limited(SEHK:3681) added to S&P Global BMI Index | CI |
| 08-31 | SinoMab BioScience Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 1.24B 1.46B 186M 166M 154M 139M 260M 17.66B 264M 1.85B 731M 9.24B 697M 682M 29.24B | P/E 2024 |
-5.94x | P/E 2025 | -14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.2B 1.41B 180M 161M 149M 135M 252M 17.1B 256M 1.79B 708M 8.95B 675M 660M 28.33B | EV / Sales 2024 |
735x | EV / Sales 2025 | - |
| Free-Float |
65.57% | Yield 2024 * |
-
| Yield 2025 | - |
Hong Kong S.E.HKD
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 3681 | Delayed | |
Tradegate
| 4VF | Real-time | |
|
Deutsche Boerse AG
| 4VF | Delayed | |
|
Deutsche Boerse AG
| 4VF | End-of-day quote | |
|
Boerse Muenchen
| 4VF | Real-time |
| 1 day | -1.43% | ||
| 1 week | -4.17% | ||
| Current month | +3.50% | ||
| 1 month | +1.47% | ||
| 3 months | -15.16% | ||
| 6 months | -31.91% | ||
| Current year | -22.76% |
| 1 week | 1.02 |  | 1.12 |
| 1 month | 0.96 | | 1.24 |
| Current year | 0.96 | | 2.19 |
| 1 year | 0.96 | | 2.19 |
| 3 years | 0.8 | | 3.76 |
| 5 years | 0.8 | | 3.76 |
| 10 years | 0.8 | | 7.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shui On Leung
CEO | Chief Executive Officer | 66 | 2002-12-31 |
Jian Ping Hua
DFI | Director of Finance/CFO | 44 | 2018-12-31 |
Guo Lin Xu
CTO | Chief Tech/Sci/R&D Officer | 42 | 2009-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ping Cho Hon
BRD | Director/Board Member | 66 | 2019-10-30 |
Shui On Leung
CHM | Chairman | 66 | 2001-04-26 |
| Director/Board Member | 84 | 2019-12-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/18/26 | Other | Chief Operating Officer | -11,093,040 | 0.8000% | ||
| 7/24/26 | Other | Chief Operating Officer | 11,093,040 | 0.8000% | ||
| 11/11/24 | Other | Director | 10,062,400 | 0.9217% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.43% | -4.17% | -38.76% | -7.59% | 186M | |
| +0.45% | +3.13% | +54.96% | +125.16% | 1,140B | |
| +0.94% | +4.93% | +39.86% | +78.72% | 641B | |
| +0.39% | +1.44% | +25.77% | +97.48% | 507B | |
| +1.43% | +4.31% | +46.20% | +67.12% | 383B | |
| -3.21% | -2.10% | +60.72% | +33.22% | 347B | |
| -0.41% | +2.64% | +22.48% | +49.82% | 293B | |
| +0.23% | +3.66% | +2.57% | +23.69% | 266B | |
| +1.22% | +4.63% | +52.40% | +64.85% | 240B | |
| +1.70% | +3.67% | +31.21% | +102.15% | 197B | |
| Average | +0.10% | +2.18% | +29.74% | +63.46% | 401.4B | |
| Weighted average by Cap. | +0.44% | +2.98% | +41.36% | +83.80% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.03M 2.38M 304K 272K 251K 227K 426K 28.89M 433K 3.02M 1.2M 15.11M 1.14M 1.12M 47.84M | - |
| Net income | -185M -218M -27.75M -24.81M -22.96M -20.78M -38.9M -2.64B -39.54M -276M -109M -1.38B -104M -102M -4.37B | -105M -123M -15.73M -14.07M -13.02M -11.79M -22.06M -1.5B -22.42M -157M -61.96M -783M -59.05M -57.79M -2.48B |
| Net Debt | 371M 437M 55.68M 49.79M 46.06M 41.71M 78.06M 5.3B 79.34M 554M 219M 2.77B 209M 205M 8.77B | -38.76M -45.57M -5.81M -5.19M -4.81M -4.35M -8.14M -553M -8.28M -57.83M -22.88M -289M -21.8M -21.34M -915M |
Employees
73
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | HK$1.035 | -1.43% | 43,500 |
| 26-10-26 | HK$1.050 | 0.00% | 262,500 |
| 26-10-23 | HK$1.050 | -5.83% | 561,900 |
| 26-10-22 | HK$1.115 | +3.72% | 216,600 |
| 26-10-21 | HK$1.075 | -0.46% | 127,500 |
- Stock Market
- Stocks
- 3681 Stock
Select your edition
All financial news and data tailored to specific country editions
